Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD

22 Jul 2020

Abstract excerpt

Lung cancer has been the focus of attention for many researchers in recent years for the leading contribution to cancer-related death worldwide, in which lung adenocarcinoma (LUAD) is the most common histological type. However, the potential mechanism behind LUAD initiation and progression remains unclear. Aiming to dissect the tumor microenvironment of LUAD and to discover more informative prognosis signatures,...

Topics

Join the communities discussing this publication.

Cancer-related molecular mechanisms research
Epigenetics and DNA Methylation
Ferroptosis and cancer prognosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32805489
DOI: 10.1016/j.omtn.2020.07.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUADPMID 32805489Read ↗

Development of a Tumour Metabolism and Immune Microenvironment-Based Prognostic Model for Prognosis and Anti-Cancer Drug Response in Lung AdenocarcinomaSemantic proximity Read ↗

Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.Semantic proximity Read ↗

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung AdenocarcinomaSemantic proximity Read ↗

Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response predictionSemantic proximity Read ↗

A novel basement membrane-related gene signature for prognosis of lung adenocarcinomasSemantic proximity Read ↗

Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinomaSemantic proximity Read ↗

Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma.Semantic proximity Read ↗

Prediction of Prognosis, Efficacy of Lung Adenocarcinoma by Machine Learning Model Based on Immune and Metabolic Related GenesSemantic proximity Read ↗

Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung AdenocarcinomasSemantic proximity Read ↗

A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung AdenocarcinomaSemantic proximity Read ↗

A Novel Fatty Acid Metabolism Signature Predicts Prognoses, Tumor Immune Microenvironment, and Immunotherapy Response In Lung AdenocarcinomaSemantic proximity Read ↗

Long non-coding RNA C5orf64 is a potential indicator for tumor microenvironment and mutation pattern remodeling in lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.